Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 182
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03479151 | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC | ||
| NCT01658930 | Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT02407509 | Phase I Trial of VS-6766 Alone and in Combination With Everolimus | ||
| NCT04901468 | A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies. | ||
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT01006564 | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors | ||
| NCT00253409 | Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT03327662 | Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT01737255 | Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome | ||
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC) | ||
| NCT05840549 | A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement | ||
| NCT02296801 | A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | ||
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | ||
| NCT00107497 | Radiation Therapy in Treating Women With Localized Breast Cancer | ||
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | ||
| NCT05968417 | Myeloma Novel Drug Discovery Ver 1.2 | ||
| NCT04458311 | Abiraterone Acetate in Combination With Tildrakizumab | ||
| NCT00028756 | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | ||
| NCT03673787 | A Trial of Ipatasertib in Combination With Atezolizumab | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT00031850 | Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT01024283 | Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 Inhibitor | ||
| NCT02780375 | Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects | ||
| NCT03727698 | Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment | ||
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer | ||
| NCT02380027 | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | ||
| NCT04686188 | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer | ||
| NCT01685190 | A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT03875820 | Phase I Trial of Defactinib and VS-6766. | ||
| NCT02978014 | A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy | ||
| NCT05368298 | SCOOT: Sample Collection for DART | ||
| NCT01099423 | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer | ||
| NCT01332968 | A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) | ||
| NCT02437227 | A Phase I, First in Man Study to Evaluate the Safety and Tolerability of a panRAF Inhibitor (CCT3833/BAL3833)in Patients With Solid Tumours | ||
| NCT05065086 | Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence | ||
| NCT03256981 | Stereotactic Body Radiotherapy for the Treatment of OPD | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | ||
| NCT05810467 | The Active Surveillance Study |
